Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/112224
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Costs of potentially inappropriate medication use in residential aged care facilities
Author: Harrison, S.
Kouladjian O'Donnell, L.
Milte, R.
Dyer, S.
Gnanamanickam, E.
Bradley, C.
Liu, E.
Hilmer, S.
Crotty, M.
Citation: BMC Geriatrics, 2018; 18(1):9-1-9-10
Publisher: BioMed Central
Issue Date: 2018
ISSN: 1471-2318
1471-2318
Statement of
Responsibility: 
S. L. Harrison, L. Kouladjian O’Donnell, R. Milte, S. M. Dyer, E. S. Gnanamanickam, C. Bradley, E. Liu, S. N. Hilmer and M. Crotty
Abstract: The potential harms of some medications may outweigh their potential benefits (inappropriate medication use). Despite recommendations to avoid the use of potentially inappropriate medications (PIMs) in older adults, the prevalence of PIM use is high in different settings including residential aged care. However, it remains unclear what the costs of these medications are in this setting. The main objective of this study was to determine the costs of PIMs in older adults living in residential care. A secondary objective was to examine if there was a difference in costs of PIMs in a home-like model of residential care compared to an Australian standard model of care.Participants included 541 participants from the Investigation Services Provided in the Residential Environment for Dementia (INSPIRED) Study. The INSPIRED study is a cross-sectional study of 17 residential aged care facilities in Australia. 12 month medication costs were determined for the participants and PIMs were identified using the 2015 updated Beers Criteria for older adults.Of all of the medications dispensed in 1 year, 15.9% were PIMs and 81.4% of the participants had been exposed to a PIM. Log-linear models showed exposure to a PIM was associated with higher total medication costs (Adjusted β = 0.307, 95% CI 0.235 to 0.379, p < 0.001). The mean proportion (±SD) of medication costs that were spent on PIMs in 1 year was 17.5% (±17.8) (AUD$410.89 ± 479.45 per participant exposed to a PIM). The largest PIM costs arose from proton-pump inhibitors (34.4%), antipsychotics (21.0%) and benzodiazepines (18.7%). The odds of incurring costs from PIMs were 52% lower for those residing in a home-like model of care compared to a standard model of care.The use of PIMs for older adults in residential care facilities is high and these medications represent a substantial cost which has the potential to be lowered. Further research should investigate whether medication reviews in this population could lead to potential cost savings and improvement in clinical outcomes. Adopting a home-like model of residential care may be associated with reduced prevalence and costs of PIMs.
Keywords: Beers criteria; Cognitive impairment; Dementia; Older adults; Potentially inappropriate medications
Rights: © The Author(s). 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
RMID: 0030086733
DOI: 10.1186/s12877-018-0704-8
Grant ID: http://purl.org/au-research/grants/nhmrc/9100000
Appears in Collections:Public Health publications

Files in This Item:
File Description SizeFormat 
hdl_112224.pdfPublished version441.95 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.